SynthesisBMC cancer2025

Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data.

Martin Kortüm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.